What is Nova-Tech?
Established in 1988, Nova-Tech Animal Health operates as a premier provider of sterile manufacturing solutions tailored exclusively for the veterinary and animal health industries. By focusing on flexible, scalable production processes, the company addresses the complex supply chain requirements of its enterprise-level clientele. Its U.S.-based facilities are optimized for rapid deployment and nationwide logistics, positioning the firm as a vital infrastructure partner for pharmaceutical and health-focused organizations seeking reliable, high-compliance manufacturing capabilities.
How much funding has Nova-Tech raised?
Nova-Tech has raised a total of $888K across 2 funding rounds:
Debt
$350K
Debt
$538K
Debt (2020): $350K with participation from PPP
Debt (2021): $538K led by PPP
Key Investors in Nova-Tech
PPP
Public-Private Partnership
What's next for Nova-Tech?
With the recent infusion of capital, Nova-Tech is well-positioned to accelerate its strategic growth initiatives. The company is expected to leverage this financing to enhance its manufacturing throughput and potentially expand its technological footprint within the sterile production space. As the animal health sector continues to demand higher standards of quality and faster turnaround times, Nova-Tech's focus on operational excellence and infrastructure investment will likely serve as a primary driver for its continued market leadership and competitive differentiation in the coming fiscal periods.
See full Nova-Tech company page
